Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Landsteiner Lung Cancer Research Platform (LALUCA) A Prospective Analysis of Lung Cancer Diagnosis and Management in Clinical Practice

NCT04733430 is registered in ClinicalTrials.gov with Karl Landsteiner Institute for Lung Research and Pneumological Oncology as lead sponsor.

NCT NCT04733430
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04733430 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Landsteiner Lung Cancer Research Platform (LALUCA) A Prospective Analysis of Lung Cancer Diagnosis and Management in Clinical Practice
Lead sponsor
Karl Landsteiner Institute for Lung Research and Pneumological Oncology
Phase
Observational
Overall status
Recruiting
Start date
April 17, 2020
Completion date
April 30, 2030
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer